In MS, pro-inflammatory cytokines, such as TNF-α, IL-1α, and IL-1β, along with Th1 and Th17 cells, are upregulated (Kebir et al., 2007; Becher et al., 2017). The gene discussed is IL1A; the disease is myeloid sarcoma.